Question 1

What are the most cited papers from BioMarin (Netherlands)?

Accepted Answer

The most cited paper from BioMarin (Netherlands) is "Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib" (Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al., 2015), with 442 citations. Next come "Benchmarking of commercially available CHO cell culture media for antibody production" (146) and "Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy" (136).

Question 2

Which research topics does BioMarin (Netherlands) publish most on?

Accepted Answer

By volume in 2022-now: Cardiovascular Function and Risk Factors, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Fibroblast Growth Factor Research.

Question 3

Which fields of science does BioMarin (Netherlands) work in?

Accepted Answer

In all years, 69% of research at BioMarin (Netherlands) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (58%), Medicine (24%), Neuroscience (10%). It does 2.7× the world's share of Life Sciences.

Question 4

Is BioMarin (Netherlands)'s research output growing?

Accepted Answer

Output in 2022-2025 was 79% lower than in 2018-2021.